Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Resilient Water Accelerator aims to bring clean water to 50m people by 2030 — and could use the capital markets to help it deliver -
New borrower is the lowest rated IG name of the week to bring a trade
-
Swiss pharma firm's stock rose after it announced dilutive block trade
-
Global agencies battling to solve Africa’s glaringly low Covid vaccination rates face indifference, obstinacy and ‘me first’ attitudes in developed world.
-
The world economy is recovering strongly from the pandemic, but low and middle income countries are being left behind. They are looking to the North for vaccines, leniency on debt and fresh development financing
-
US medtech firm raises €5.25bn for acquisition
